tiprankstipranks
Venus Medtech (Hangzhou), Inc. Class H (HK:2500)
:2500
Hong Kong Market
2500
Venus Medtech (Hangzhou), Inc. Class H
RESEARCH TOOLSreports
Want to see HK:2500 full AI Analyst Report?

Venus Medtech (Hangzhou), Inc. Class H (2500) Financial Statements

0 Followers

Venus Medtech (Hangzhou), Inc. Class H Financial Overview

Venus Medtech (Hangzhou), Inc. Class H's market cap is currently HK$582.14M. The company's EPS TTM is HK$-0.93; its P/E ratio is -2.30; Venus Medtech (Hangzhou), Inc. Class H is scheduled to report earnings on March 31, 2026, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue¥ 306.79M¥ 470.83M¥ 491.37M¥ 406.46M¥ 415.86M
Gross Profit¥ 211.83M¥ 367.75M¥ 389.20M¥ 314.00M¥ 324.34M
Operating Income¥ -345.32M¥ -346.60M¥ -589.97M¥ -650.21M¥ -278.64M
EBITDA¥ -315.42M¥ -612.96M¥ -547.84M¥ -999.37M¥ -324.03M
Net Income¥ -407.69M¥ -714.31M¥ -703.75M¥ -1.06B¥ -373.64M
Balance Sheet
Cash & Short-Term Investments¥ 280.52M¥ 305.70M¥ 781.64M¥ 1.88B¥ 2.96B
Total Assets¥ 2.52B¥ 3.25B¥ 4.41B¥ 5.28B¥ 5.11B
Total Debt¥ 216.43M¥ 369.09M¥ 826.19M¥ 899.64M¥ 70.78M
Net Debt¥ 41.39M¥ 71.05M¥ 51.79M¥ -979.79M¥ -2.88B
Total Liabilities¥ 757.14M¥ 1.04B¥ 1.49B¥ 1.65B¥ 477.61M
Stockholders' Equity¥ 1.76B¥ 2.21B¥ 2.92B¥ 3.61B¥ 4.55B
Cash Flow
Free Cash Flow¥ -332.12M¥ -17.82M¥ -872.93M¥ -908.23M¥ -602.08M
Operating Cash Flow¥ -321.35M¥ 23.74M¥ -610.02M¥ -729.46M¥ -456.92M
Investing Cash Flow¥ 364.06M¥ -19.90M¥ -346.86M¥ -1.07B¥ -653.04M
Financing Cash Flow¥ -184.05M¥ -487.34M¥ -173.99M¥ 635.14M¥ 1.39B
Currency in CNY

Venus Medtech (Hangzhou), Inc. Class H Earnings and Revenue History

Income Statement >

Venus Medtech (Hangzhou), Inc. Class H Debt to Assets

Balance Sheet >

Venus Medtech (Hangzhou), Inc. Class H Cash Flow

Cash Flow >

Venus Medtech (Hangzhou), Inc. Class H Forecast EPS vs Actual EPS

Earnings >